Includes: 25 Test Kits, 25 Pipette, 1 Vial Buffer Solution
Performance: COVID-19 IgG/IgM Rapid Test Device
- Relative Sensitivity: 93.7%
- Relative Specificity: 99.1%
- Overall Agreement: 97.7%
- Not to be used as sole diagnosis – very high sensitivity and specificity allows providers to make an informed decision for next step of treatment.
Results: Results are displayed as positive/negative within 10 minutes of providing the sample.
Supply Quality – Manufacturing facility has been producing high quality, FDA approved / CLIA waived onsite diagnostic kits for 20+ years.
COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to 2019 Novel Coronavirus in human whole blood, serum or plasma.
The test has been reviewed by the FDA and approved under the FDA EUA. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
BULK KIT PRICING FOR KITS OR MORE AVAILABLE